Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modelling the Human Blood–Brain Barrier in Huntington Disease
Domenico Vignone, Odalys Gonzalez Paz, Ivan Fini, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7813-7813
Open Access | Times Cited: 11

Showing 11 citing articles:

Blood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models
Sarah E. Brandl, Markus Reindl
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12699-12699
Open Access | Times Cited: 28
Breaking Barriers in Huntington’s Disease Therapy: Focused Ultrasound for Targeted Drug Delivery
M.D. HEBAT-ALLAH G. RASHED SHAABAN R. HELAL, Amna Ibrahim, Ahmad Beddor, et al.
Neurochemical Research (2025) Vol. 50, Iss. 1
Open Access | Times Cited: 1
Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration
Carlos Estevez‐Fraga, André Altmann, Christopher S. Parker, et al.
Brain (2023) Vol. 146, Iss. 11, pp. 4532-4546
Open Access | Times Cited: 15
Glial cells: an important switch for the vascular function of the central nervous system
Ling Gao, Xuezhen Pan, John H. Zhang, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 14
Inflammation and Huntington’s disease- a neglected therapeutic target?
Sophie E. Field, Annabel J. Curle, Roger A. Barker
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 5, pp. 451-467
Open Access | Times Cited: 5
Endothelial Dysfunction in Huntington’s Disease: Pathophysiology and Therapeutic Implications
Na Hu, Zihao Chen, Xinyue Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1432-1432
Open Access
Peripheral and central elevation of IL-8 in patients with Huntington’s disease
Jenny N. Fung, John D. Lee, Robert Adam, et al.
Molecular Immunology (2025) Vol. 179, pp. 84-93
Open Access
Dual inhibition of canonical and noncanonical PAR‐1 by SCH79797 mitigates neurodegeneration in 3‐NP‐induced Huntington's disease: An in vivo and in silico approach
Raghda T. Abdel‐Latif, Hanan S. El‐Abhar, Dalaal M. Abdallah, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access
The hemostatic system in chronic brain diseases: A new challenging frontier?
Mathias Chéa, Sylvie Bouvier, Jean‐Christophe Gris
Thrombosis Research (2024) Vol. 243, pp. 109154-109154
Closed Access | Times Cited: 1
Bioavailability as Proof to Authorize the Clinical Testing of Neurodegenerative Drugs—Protocols and Advice for the FDA to Meet the ALS Act Vision
Sarfaraz K. Niazi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10211-10211
Open Access | Times Cited: 1
Understanding the Role of CDH4 in Multiple System Atrophy Brain
Finula I. Isik, Jared S. Katzeff, Yuhong Fu, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 8, pp. 1303-1311
Open Access
Page 1

Scroll to top